More News
7 September 2021
National Cancer Institute (NCI) Awards Isoprene Pharmaceuticals, Inc. a Two-Year $2 Million Small Business Innovation Research (SBIR) Grant3 September 2021
Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration31 August 2021
Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research30 August 2021
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-00426 August 2021
NovaRock Biotherapeutics Announces Exclusive License Agreement and Strategic Partnership with Flame BioSciences24 August 2021
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets24 August 2021
Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell Therapies23 August 2021
Pfizer to Acquire Trillium Therapeutics Inc.18 August 2021
Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation3 August 2021
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development2 August 2021
Autolus and Moderna sign Option and License Agreement for access to proprietary targeting technology from AutolusNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports